{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:55:59Z","timestamp":1790081759778,"version":"4.0.1"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RA.KKU\/30\/44"],"award-info":[{"award-number":["RA.KKU\/30\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.lfs.2023.122087","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T01:58:18Z","timestamp":1694656698000},"page":"122087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Current understanding of structural and molecular changes in diabetic cardiomyopathy"],"prefix":"10.1016","volume":"332","author":[{"given":"Md Sayeed","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirajudeen S.","family":"Alavudeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Tarique","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad Saeed","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fauzia","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Javid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.122087_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchf.2022.11.018","article-title":"Prevention supersedes prediction of worsening heart failure","volume":"11","author":"Costanzo","year":"2023","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.lfs.2023.122087_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.679","article-title":"ESC-HFA HF long-term registry investigators, in-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA heart failure long-term registry","volume":"19","author":"Targher","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.lfs.2023.122087_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000222","article-title":"Clinical prediction of incident heart failure risk: a systematic review and meta-analysis","volume":"2","author":"Yang","year":"2015","journal-title":"Open Heart."},{"key":"10.1016\/j.lfs.2023.122087_bb0025","doi-asserted-by":"crossref","first-page":"154910","DOI":"10.1016\/j.metabol.2021.154910","article-title":"Heart failure in diabetes","volume":"125","author":"Jankauskas","year":"2021","journal-title":"Metabolism."},{"key":"10.1016\/j.lfs.2023.122087_bb0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/1573399812666150914120529","article-title":"Present insights on cardiomyopathy in diabetic patients","volume":"12","author":"Fel\u00edcio","year":"2016","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.lfs.2023.122087_bb0035","article-title":"Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: a systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.122087_bb0040","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.lfs.2023.122087_bb0045","unstructured":"IDF Diabetes Atlas. (n.d.). https:\/\/diabetesatlas.org\/idfawp\/resource-files\/2021\/07\/IDF_Atlas_10th_Edition_2021.pdf (accessed March 18, 2023)."},{"key":"10.1016\/j.lfs.2023.122087_bb0050","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2023.122087_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almor\u00f3s","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2023.122087_bb0060","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0065","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: Current and future therapies. Beyond glycemic control","volume":"9","author":"Borghetti","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0070","doi-asserted-by":"crossref","first-page":"8347891","DOI":"10.1155\/2019\/8347891","article-title":"Corrigendum to \u201cThe impact of type 2 diabetes mellitus on long-term prognosis in patients of different ages with myocardial infarction\u201d","volume":"2019","author":"Afanasiev","year":"2019","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.lfs.2023.122087_bb0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4239\/wjd.v7.i17.354","article-title":"Update on the treatment of type 2 diabetes mellitus","volume":"7","author":"Mar\u00edn-Pe\u00f1alver","year":"2016","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.lfs.2023.122087_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10741-013-9377-8","article-title":"Metabolic dysfunction in diabetic cardiomyopathy","volume":"19","author":"Isfort","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.lfs.2023.122087_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12933-015-0173-8","article-title":"Targeting metabolic disturbance in the diabetic heart","volume":"14","author":"Fuentes-Antr\u00e1s","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2023.122087_bb0095","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1253\/circj.CJ-13-1564","article-title":"Diabetes-related heart failure: - does diabetic cardiomyopathy exist?","volume":"78","author":"Bando","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.lfs.2023.122087_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jdiacomp.2007.12.005","article-title":"Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options","volume":"23","author":"Mytas","year":"2009","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.lfs.2023.122087_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.lfs.2023.122087_bb0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/0960327112450885","article-title":"Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion: pathophysiological mechanisms and cardiac dysfuntion","volume":"32","author":"Goyal","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.lfs.2023.122087_bb0115","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0120","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3390\/jcm9092880","article-title":"Coronary microvascular dysfunction","volume":"9","author":"Vancheri","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2023.122087_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12933-019-0833-1","article-title":"Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease","volume":"18","author":"Sara","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2023.122087_bb0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.trsl.2019.03.004","article-title":"Mechanisms of cardiac collagen deposition in experimental models and human disease","volume":"209","author":"Cowling","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1291\/hypres.30.439","article-title":"Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart","volume":"30","author":"Tsutsui","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/VHRM.S1991","article-title":"Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers","volume":"4","author":"Ban","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.lfs.2023.122087_bb0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphar.2020.00042","article-title":"Distinct types of cell death and the implication in diabetic cardiomyopathy","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122087_bb0150","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2337\/db08-0617","article-title":"Rac1 is required for cardiomyocyte apoptosis during hyperglycemia","volume":"58","author":"Shen","year":"2009","journal-title":"Diabetes."},{"key":"10.1016\/j.lfs.2023.122087_bb0155","doi-asserted-by":"crossref","first-page":"8917578","DOI":"10.1155\/2016\/8917578","article-title":"Update on RAAS modulation for the treatment of diabetic cardiovascular disease","volume":"2016","author":"Bernardi","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fnins.2018.00591","article-title":"Cardiac autonomic neuropathy in diabetes: a predictor of cardiometabolic events","volume":"12","author":"Vinik","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.lfs.2023.122087_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12947-019-0167-x","article-title":"Clinical value of myocardial performance index in patients with isolated diastolic dysfunction","volume":"17","author":"Fernandes","year":"2019","journal-title":"Cardiovasc. Ultrasound"},{"key":"10.1016\/j.lfs.2023.122087_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9149(91)90716-X","article-title":"Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study)","volume":"68","author":"Galderisi","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0175","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population","volume":"101","author":"Eguchi","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0180","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2337\/db08-1192","article-title":"Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the multi-ethnic study of atherosclerosis","volume":"58","author":"Rerkpattanapipat","year":"2009","journal-title":"Diabetes."},{"key":"10.1016\/j.lfs.2023.122087_bb0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ahj.2004.06.021","article-title":"Screening for heart disease in diabetic subjects","volume":"149","author":"Fang","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2023.122087_bb0190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1463-1326.2007.00803.x","article-title":"Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes","volume":"10","author":"Brooks","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.lfs.2023.122087_bb0195","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/CIRCULATIONAHA.108.803916","article-title":"Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus","volume":"119","author":"van der Meer","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2023.122087_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERP-17-0054","article-title":"Contractile reserve as a predictor of prognosis in patients with non-ischaemic systolic heart failure and dilated cardiomyopathy: a systematic review and meta-analysis","volume":"5","author":"Waddingham","year":"2018","journal-title":"Echo Res. Pract."},{"key":"10.1016\/j.lfs.2023.122087_bb0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/FJC.0b013e3181ac3a34","article-title":"TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes","volume":"54","author":"Joshi","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122087_bb0210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.109.200501","article-title":"Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease: a new link between obesity and heart disease","volume":"105","author":"Lamounier-Zepter","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurheartj\/ehp396","article-title":"Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction","volume":"31","author":"Cook","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2023.122087_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1677\/joe.1.06241","article-title":"Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob\/ob obese mice","volume":"188","author":"Dong","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.lfs.2023.122087_bb0225","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1096\/fj.04-2263com","article-title":"Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart","volume":"18","author":"Sharma","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2023.122087_bb0230","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/joim.12728","article-title":"Manifestations and mechanisms of myocardial lipotoxicity in obesity","volume":"284","author":"Sletten","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lfs.2023.122087_bb0235","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI108843","article-title":"Evidence for cardiomyopathy in familial diabetes mellitus","volume":"60","author":"Regan","year":"1977","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.122087_bb0240","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study: a 1 H-magnetic resonance spectroscopy study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2023.122087_bb0245","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0250","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1194\/jlr.M600299-JLR200","article-title":"Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death","volume":"47","author":"Borradaile","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0255","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1074\/jbc.M806209200","article-title":"The non-coding RNA gadd7 is a regulator of lipid-induced oxidative and endoplasmic reticulum stress","volume":"284","author":"Brookheart","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122087_bb0260","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/ijms21072413","article-title":"Role of oxidative stress in metabolic and subcellular abnormalities in diabetic cardiomyopathy","volume":"21","author":"Dhalla","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122087_bb0265","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01142.2008","article-title":"Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH","volume":"297","author":"Serpillon","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.592688","article-title":"The relationship between reactive oxygen species and endothelial cell metabolism","volume":"8","author":"Alhayaza","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.lfs.2023.122087_bb0275","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.bbamcr.2017.05.007","article-title":"The role of matrix metalloproteinases in aging: tissue remodeling and beyond","volume":"1864","author":"Freitas-Rodr\u00edguez","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0280","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12272-021-01307-9","article-title":"Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases","volume":"44","author":"Seok","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10974-017-9470-z","article-title":"Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor","volume":"38","author":"Santulli","year":"2017","journal-title":"J. Muscle Res. Cell Motil."},{"key":"10.1016\/j.lfs.2023.122087_bb0290","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3389\/fphys.2018.01775","article-title":"Redox dependent modifications of ryanodine receptor: basic mechanisms and implications in heart diseases","volume":"9","author":"Nikolaienko","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0295","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/ijms20112833","article-title":"Contribution of impaired insulin signaling to the pathogenesis of diabetic cardiomyopathy","volume":"20","author":"Zamora","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122087_bb0300","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin","volume":"28","author":"Muniyappa","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2023.122087_bb0305","doi-asserted-by":"crossref","first-page":"H435","DOI":"10.1152\/ajpheart.00597.2018","article-title":"Innate immune response in the pathogenesis of heart failure in survivors of myocardial infarction","volume":"316","author":"Zimmer","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0310","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0315","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2023.122087_bb0320","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/HYPERTENSIONAHA.115.06015","article-title":"Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females","volume":"66","author":"Jia","year":"2015","journal-title":"Hypertension."},{"key":"10.1016\/j.lfs.2023.122087_bb0325","article-title":"Effects of four weeks intermittent hypoxia intervention on glucose homeostasis, insulin sensitivity, GLUT4 translocation, insulin receptor phosphorylation, and Akt activity in skeletal muscle of obese mice with type 2 diabetes","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.122087_bb0330","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"281","author":"Randle","year":"1963","journal-title":"Lancet."},{"key":"10.1016\/j.lfs.2023.122087_bb0335","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/cvr\/cvp017","article-title":"Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding","volume":"82","author":"Wright","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0340","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12933-020-01188-0","article-title":"Impact of peroxisome proliferator-activated receptor-\u03b1 on diabetic cardiomyopathy","volume":"20","author":"Wang","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2023.122087_bb0345","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.CIR.0000026392.80723.DC","article-title":"Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure","volume":"106","author":"Razeghi","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2023.122087_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.lfs.2023.122087_bb0355","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.bbadis.2017.11.013","article-title":"Evaluation of cardiac energetics by non-invasive 31P magnetic resonance spectroscopy","volume":"1864","author":"Abdurrachim","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2023.122087_bb0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcvm.2020.00037","article-title":"Receptor for advanced glycation end products (RAGE) and mechanisms and therapeutic opportunities in diabetes and cardiovascular disease: insights from human subjects and animal models","volume":"7","author":"Ega\u00f1a-Gorro\u00f1o","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.lfs.2023.122087_bb0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s10020-018-0060-3","article-title":"The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review","volume":"24","author":"Fishman","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2023.122087_bb0370","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1093\/cvr\/cvy160","article-title":"Potential cardiovascular implications of Janus kinase inhibitors in immune mediated diseases","volume":"114","author":"Mehta","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0375","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bbadis.2019.01.006","article-title":"Impact of advanced glycation end products (AGEs) signaling in coronary artery disease","volume":"1865","author":"Kosmopoulos","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2023.122087_bb0380","doi-asserted-by":"crossref","first-page":"5732956","DOI":"10.1155\/2020\/5732956","article-title":"The role of oxidative stress in cardiac disease: from physiological response to injury factor","volume":"2020","author":"D\u2019Oria","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2023.122087_bb0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lfs.2017.08.029","article-title":"Autophagy: the spotlight for cellular stress responses","volume":"188","author":"Ravanan","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2023.122087_bb0390","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cell.2014.11.006","article-title":"Metabolic control of autophagy","volume":"159","author":"Galluzzi","year":"2014","journal-title":"Cell."},{"key":"10.1016\/j.lfs.2023.122087_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121427","article-title":"The role of autophagy in the heart","volume":"80","author":"Sciarretta","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0400","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.bbadis.2017.03.013","article-title":"Role of microRNA in diabetic cardiomyopathy: from mechanism to intervention","volume":"1863","author":"Guo","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2023.122087_bb0405","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3390\/cells9102315","article-title":"Novel insights into the cellular localization and regulation of the autophagosomal proteins LC3A, LC3B and LC3C","volume":"9","author":"Baeken","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.lfs.2023.122087_bb0410","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2007.11.004","article-title":"FoxO3 coordinately activates protein degradation by the autophagic\/lysosomal and proteasomal pathways in atrophying muscle cells","volume":"6","author":"Zhao","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2023.122087_bb0415","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yjmcc.2015.11.019","article-title":"Therapeutic targeting of autophagy in cardiovascular disease","volume":"95","author":"Schiattarella","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0420","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/db10-0351","article-title":"Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice","volume":"60","author":"Xie","year":"2011","journal-title":"Diabetes."},{"key":"10.1016\/j.lfs.2023.122087_bb0425","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncb2211","article-title":"Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism","volume":"13","author":"Jordan","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2023.122087_bb0430","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"Trajkovski","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2023.122087_bb0435","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1073\/pnas.0710228105","article-title":"Targeted deletion of dicer in the heart leads to dilated cardiomyopathy and heart failure","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.122087_bb0440","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12265-010-9172-z","article-title":"MicroRNAs in cardiovascular diseases: biology and potential clinical applications","volume":"3","author":"Kartha","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0445","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.110.239111","article-title":"Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling","volume":"108","author":"Katare","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0450","doi-asserted-by":"crossref","first-page":"28656","DOI":"10.1074\/jbc.A111.700015","article-title":"MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts","volume":"286","author":"Xiao","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122087_bb0455","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling: implications for a role of MicroRNAs in myocardial matrix remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0460","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0465","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cvr\/cvr300","article-title":"Role of microRNAs in diabetes and its cardiovascular complications","volume":"93","author":"Shantikumar","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0470","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0022034509335868","article-title":"Epigenetics: connecting environment and genotype to phenotype and disease","volume":"88","author":"Barros","year":"2009","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0475","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.lfs.2023.122087_bb0480","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/icb.2011.100","article-title":"HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications","volume":"90","author":"Khan","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.lfs.2023.122087_bb0485","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yjmcc.2010.11.009","article-title":"Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart","volume":"51","author":"McKinsey","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0490","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2217\/epi-2019-0027","article-title":"Epigenetics in the development of diabetic cardiomyopathy","volume":"11","author":"Pepin","year":"2019","journal-title":"Epigenomics."},{"key":"10.1016\/j.lfs.2023.122087_bb0495","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2023.122087_bb0500","doi-asserted-by":"crossref","first-page":"F14","DOI":"10.1152\/ajprenal.00200.2010","article-title":"The role of epigenetics in the pathology of diabetic complications","volume":"299","author":"Villeneuve","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0505","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/00015385.2022.2115761","article-title":"Levosimendan: mechanistic insight and its diverse future aspects in cardiac care","volume":"78","author":"Akhtar","year":"2023","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0510","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCHEARTFAILURE.108.802116","article-title":"Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure","volume":"1","author":"Guazzi","year":"2008","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.lfs.2023.122087_bb0515","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.bmcl.2005.02.083","article-title":"Optimization of purine based PDE1\/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED","volume":"15","author":"Boyle","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2023.122087_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.569132","article-title":"Trimetazidine in heart failure","volume":"11","author":"Shu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122087_bb0525","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2019.05.063","article-title":"Trimetazidine in cardiovascular medicine","volume":"293","author":"Marzilli","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0530","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/hrt.2010.208751","article-title":"Trimetazidine: a meta-analysis of randomised controlled trials in heart failure","volume":"97","author":"Gao","year":"2011","journal-title":"Heart."},{"key":"10.1016\/j.lfs.2023.122087_bb0535","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/hrt.2011.226332","article-title":"Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure","volume":"97","author":"Fragasso","year":"2011","journal-title":"Heart."},{"key":"10.1016\/j.lfs.2023.122087_bb0540","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10741-009-9136-z","article-title":"Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?","volume":"14","author":"Khan","year":"2009","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.lfs.2023.122087_bb0545","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2009.03.007","volume":"157","author":"Shah","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2023.122087_bb0550","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/ejhf.1743","article-title":"Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial","volume":"22","author":"Carubelli","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.lfs.2023.122087_bb0555","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.jacc.2012.07.012","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary","volume":"60","author":"Fihn","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0560","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"Members","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2023.122087_bb0565","doi-asserted-by":"crossref","first-page":"174787","DOI":"10.1016\/j.ejphar.2022.174787","article-title":"Role of ranolazine in heart failure: from cellular to clinic perspective","volume":"919","author":"Kaplan","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122087_bb0570","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchf.2012.12.002","article-title":"RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study","volume":"1","author":"Maier","year":"2013","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.lfs.2023.122087_bb0575","first-page":"66","article-title":"Ranolazine preserves and improves left ventricular ejection fraction and autonomic measures when added to guideline-driven therapy in chronic heart failure","volume":"9","author":"Murray","year":"2014","journal-title":"Heart Int."},{"key":"10.1016\/j.lfs.2023.122087_bb0580","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/antiox10050755","article-title":"The use of coenzyme Q10 in cardiovascular diseases","volume":"10","author":"Rabanal-Ruiz","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.lfs.2023.122087_bb0585","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.ihj.2018.01.031","article-title":"Coenzyme Q10 in the treatment of heart failure: a systematic review of systematic reviews","volume":"70","author":"Jafari","year":"2018","journal-title":"Indian Heart J."},{"key":"10.1016\/j.lfs.2023.122087_bb0590","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.lfs.2023.122087_bb0595","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11897-022-00539-0","article-title":"Mitochondria as therapeutic targets in heart failure","volume":"19","author":"Schwemmlein","year":"2022","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.lfs.2023.122087_bb0600","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004389","article-title":"Novel mitochondria-targeting peptide in heart failure treatment: a randomized, placebo-controlled trial of elamipretide","volume":"10","author":"Daubert","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.lfs.2023.122087_bb0605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1755-5922.2009.00120.x","article-title":"Insulin signaling: a possible pathogenesis of cardiac hypertrophy","volume":"28","author":"Yu","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.lfs.2023.122087_bb0610","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ijo.2017.239","article-title":"The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity","volume":"42","author":"Rayner","year":"2018","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.lfs.2023.122087_bb0615","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","article-title":"Activation of protein kinase C isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0620","series-title":"Diabetic Cardiomyopathy","first-page":"269","article-title":"Roles of PKC isoforms in development of diabetes-induced cardiovascular complications","author":"Ozakca","year":"2014"},{"key":"10.1016\/j.lfs.2023.122087_bb0625","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cvr\/cvx097","article-title":"The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall","volume":"113","author":"Jia","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0630","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cardfail.2012.02.005","article-title":"Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee","volume":"18","author":"Butler","year":"2012","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.lfs.2023.122087_bb0635","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.lfs.2023.122087_bb0640","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00125-021-05380-z","article-title":"Hypoxia and hypoxia-inducible factors in diabetes and its complications","volume":"64","author":"Catrina","year":"2021","journal-title":"Diabetologia."},{"key":"10.1016\/j.lfs.2023.122087_bb0645","first-page":"76","article-title":"Effect of intermittent hypoxia on the cardiac HIF-1\/VEGF pathway in experimental type 1 diabetes mellitus","volume":"16","author":"G\u00fczel","year":"2016","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0650","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/db19-0829","article-title":"Endothelial overexpression of metallothionein prevents diabetes-induced impairment in ischemia angiogenesis through preservation of HIF-1\u03b1\/SDF-1\/VEGF signaling in endothelial progenitor cells","volume":"69","author":"Wang","year":"2020","journal-title":"Diabetes."},{"key":"10.1016\/j.lfs.2023.122087_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41401-018-0042-6","article-title":"Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy","volume":"40","author":"Knapp","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2023.122087_bb0660","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fendo.2020.00203","article-title":"Early endothelial dysfunction in type 1 diabetes is accompanied by an impairment of vascular smooth muscle function: a meta-analysis","volume":"11","author":"Lespagnol","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.lfs.2023.122087_bb0665","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1753-0407.12521","article-title":"Macro- and microvascular endothelial dysfunction in diabetes","volume":"9","author":"Shi","year":"2017","journal-title":"J. Diabetes"},{"key":"10.1016\/j.lfs.2023.122087_bb0670","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immune mechanisms in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2023.122087_bb0675","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2023.122087_bb0680","unstructured":"Regulating Inflammatory Cytokines in the Diabetic Heart, Oxidative Stress in Heart Diseases, n.d."},{"key":"10.1016\/j.lfs.2023.122087_bb0685","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.1054","article-title":"miR133a regulates cardiomyocyte hypertrophy in diabetes","volume":"26","author":"Feng","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.lfs.2023.122087_bb0690","doi-asserted-by":"crossref","first-page":"H293","DOI":"10.1152\/ajpheart.00520.2017","article-title":"Regulating microRNA expression: at the heart of diabetes mellitus and the mitochondrion","volume":"314","author":"Hathaway","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2023.122087_bb0695","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-018-0767-z","article-title":"MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin","volume":"17","author":"Dai","year":"2018","journal-title":"Cardiovasc. Diabetol."}],"updated-by":[{"DOI":"10.1016\/j.lfs.2023.122168","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000}}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523007221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523007221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:57:46Z","timestamp":1736333866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523007221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":139,"alternative-id":["S0024320523007221"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122087","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.lfs.2023.122168","asserted-by":"object"}]},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current understanding of structural and molecular changes in diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122087"}}